<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:identifier>https://scholia.toolforge.org/work/Q58701015</dc:identifier>
  <dc:identifier>http://www.wikidata.org/entity/Q58701015</dc:identifier>
  <dc:identifier>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113495</dc:identifier>
  <dc:identifier>doi:10.1128/JCM.00204-18</dc:identifier>
  <dc:title>Phase Variation of NadA in Invasive Neisseria meningitidis Isolates Impacts on Coverage Estimates for 4C-MenB, a MenB Vaccine</dc:title>
  <dc:creator>Green, Luke R</dc:creator>
  <dc:creator>Lucidarme, Jay</dc:creator>
  <dc:creator>Dave, Neelam</dc:creator>
  <dc:creator>Chan, Hannah</dc:creator>
  <dc:creator>Clark, Stephen</dc:creator>
  <dc:creator>Borrow, Ray</dc:creator>
  <dc:creator>Bayliss, Christopher D.</dc:creator>
  <dc:type>journal article</dc:type>
  <dc:date>2018-08-27</dc:date>
  <dc:language>en</dc:language>
  <dc:rights>https://creativecommons.org/licenses/by/4.0/</dc:rights>
  <dc:subject>theme:invasion impact</dc:subject>
  <dc:subject>theme:wikidata.org/entity/Q112148709</dc:subject>
  <dc:subject>Neisseria meningitidis</dc:subject>
  <dc:subject>invasive species</dc:subject>
  <dc:subject>invasion impact</dc:subject>
  <dc:publisher>American Society for Microbiology</dc:publisher>
  <dc:description>
            A recombinant NadA protein is one of the four major protective antigens of 4C-MenB (Bexsero), a vaccine developed for serogroup B
            Neisseria meningitidis
            (MenB). The meningococcal antigen typing system (MATS) is utilized as a high-throughput assay for assessing the invasive MenB strain coverage of 4C-MenB.
          </dc:description>
  <dc:coverage>n/a</dc:coverage>
</oai_dc:dc>